The Pancreatic Cancer Action Network Names Anna Berkenblit, MD, MMSc As First-Ever Chief Scientific and Medical Officer
April 03, 2024
April 03, 2024
LOS ANGELES, California, April 3 -- The Pancreatic Cancer Action Network issued the following news release:
The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit in the fight against pancreatic cancer, announces Anna Berkenblit, MD, MMSc, a clinical oncologist and drug developer, as its first-ever chief scientific and medical officer. In this role, Dr. Berkenblit will be responsible for the organization's overall scientific and clinical strategy, including PanCAN-spon . . .
The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit in the fight against pancreatic cancer, announces Anna Berkenblit, MD, MMSc, a clinical oncologist and drug developer, as its first-ever chief scientific and medical officer. In this role, Dr. Berkenblit will be responsible for the organization's overall scientific and clinical strategy, including PanCAN-spon . . .